ICLR – ICON Public Limited Company
ICLR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.68
Margin Of Safety %
56
Put/Call OI Ratio
0.58
EPS Next Q Diff
0.26
EPS Last/This Y
3.48
EPS This/Next Y
-0.42
Price
102.1
Target Price
128.83
Analyst Recom
2.18
Performance Q
-44.43
Upside
-5.8%
Beta
1.31
Ticker: ICLR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | ICLR | 108.08 | 0.42 | 0.94 | 6445 |
| 2026-03-02 | ICLR | 108.29 | 0.46 | 0.43 | 6789 |
| 2026-03-03 | ICLR | 108.77 | 0.45 | 9.64 | 7050 |
| 2026-03-04 | ICLR | 110.29 | 0.49 | 0.02 | 7087 |
| 2026-03-05 | ICLR | 110.55 | 0.50 | 0.41 | 6967 |
| 2026-03-06 | ICLR | 107.21 | 0.50 | 0.28 | 7049 |
| 2026-03-09 | ICLR | 110.16 | 0.48 | 1.97 | 7398 |
| 2026-03-10 | ICLR | 106.62 | 0.48 | 0.04 | 7320 |
| 2026-03-11 | ICLR | 105.49 | 0.48 | 0.54 | 7423 |
| 2026-03-12 | ICLR | 97.41 | 0.48 | 0.81 | 7487 |
| 2026-03-13 | ICLR | 97.45 | 0.48 | 0.82 | 7487 |
| 2026-03-17 | ICLR | 100.4 | 0.54 | 0.25 | 8543 |
| 2026-03-18 | ICLR | 97.16 | 0.53 | 0.42 | 8577 |
| 2026-03-19 | ICLR | 98.11 | 0.53 | 0.11 | 8796 |
| 2026-03-20 | ICLR | 100.42 | 0.53 | 0.30 | 8793 |
| 2026-03-23 | ICLR | 100.46 | 0.56 | 0.36 | 6338 |
| 2026-03-24 | ICLR | 101.41 | 0.55 | 0.43 | 6605 |
| 2026-03-25 | ICLR | 100.05 | 0.55 | 0.59 | 6844 |
| 2026-03-26 | ICLR | 103.16 | 0.55 | 0.89 | 6932 |
| 2026-03-27 | ICLR | 102.1 | 0.58 | 1.78 | 7374 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | ICLR | 107.98 | -4.7 | 105.7 | 13.08 |
| 2026-03-02 | ICLR | 108.32 | -4.7 | 374.5 | 13.08 |
| 2026-03-03 | ICLR | 108.76 | -4.7 | 377.0 | 13.08 |
| 2026-03-04 | ICLR | 110.18 | -4.7 | 384.5 | 13.08 |
| 2026-03-05 | ICLR | 110.57 | -4.7 | 375.7 | 13.08 |
| 2026-03-06 | ICLR | 107.24 | -4.7 | 347.4 | 13.08 |
| 2026-03-09 | ICLR | 110.13 | -5.4 | 395.0 | 13.08 |
| 2026-03-10 | ICLR | 106.62 | -5.4 | 346.7 | 13.08 |
| 2026-03-11 | ICLR | 105.44 | -5.4 | 363.5 | 13.08 |
| 2026-03-12 | ICLR | 97.41 | -5.4 | 309.4 | 13.08 |
| 2026-03-13 | ICLR | 98.33 | -5.4 | 380.7 | 13.08 |
| 2026-03-17 | ICLR | 100.46 | -5.4 | 397.2 | 13.08 |
| 2026-03-18 | ICLR | 97.16 | -5.4 | 345.6 | 13.08 |
| 2026-03-19 | ICLR | 98.28 | -5.4 | 145.6 | 13.08 |
| 2026-03-20 | ICLR | 99.70 | -5.4 | 149.1 | 13.08 |
| 2026-03-23 | ICLR | 100.41 | -5.4 | 142.5 | 13.08 |
| 2026-03-24 | ICLR | 101.26 | -5.4 | 143.6 | 13.08 |
| 2026-03-25 | ICLR | 100.00 | -5.4 | 128.7 | 13.08 |
| 2026-03-26 | ICLR | 103.20 | -5.4 | 159.2 | 13.08 |
| 2026-03-27 | ICLR | 102.10 | -5.4 | 131.6 | 13.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | ICLR | 0.00 | -2.49 | 2.64 |
| 2026-03-02 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-03 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-04 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-05 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-06 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-09 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-10 | ICLR | 0.00 | 2.68 | 2.64 |
| 2026-03-11 | ICLR | 0.00 | 2.68 | 2.55 |
| 2026-03-12 | ICLR | 0.00 | 2.68 | 2.55 |
| 2026-03-13 | ICLR | 0.00 | 2.68 | 2.55 |
| 2026-03-17 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-18 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-19 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-20 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-23 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-24 | ICLR | 0.00 | 5.09 | 2.55 |
| 2026-03-25 | ICLR | 0.00 | 5.09 | 2.68 |
| 2026-03-26 | ICLR | 0.00 | 5.09 | 2.68 |
| 2026-03-27 | ICLR | 0.00 | 5.09 | 2.68 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.83
Avg. EPS Est. Current Quarter
3.32
Avg. EPS Est. Next Quarter
3.09
Insider Transactions
Institutional Transactions
5.09
Beta
1.31
Average Sales Estimate Current Quarter
2011
Average Sales Estimate Next Quarter
1981
Fair Value
159.71
Quality Score
71
Growth Score
58
Sentiment Score
51
Actual DrawDown %
70.6
Max Drawdown 5-Year %
-76.9
Target Price
128.83
P/E
13.8
Forward P/E
8.23
PEG
P/S
0.96
P/B
0.84
P/Free Cash Flow
8.02
EPS
7.4
Average EPS Est. Cur. Y
13.08
EPS Next Y. (Est.)
12.66
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
7.4
Relative Volume
0.57
Return on Equity vs Sector %
-20.9
Return on Equity vs Industry %
-4.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
131.6
◆
ICLR
Healthcare
$102.08
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
41.4
Range 1M
37.5%
Sup Dist
0.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-7.1%
EPS NY
-4.6%
52W%
24.9%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+52.8% upside
Upside
+52.8%
Quality
71
MoS
56%
ICON plcSector: Healthcare
Industry: Diagnostics & Research
Employees: 39800
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICLR
Latest News
—
Caricamento notizie per ICLR…
stock quote shares ICLR – ICON Public Limited Company Stock Price stock today
news today ICLR – ICON Public Limited Company stock forecast ,stock prediction 2023 2024 2025
marketwatch ICLR – ICON Public Limited Company yahoo finance google finance
stock history ICLR – ICON Public Limited Company invest stock market
stock prices ICLR premarket after hours
ticker ICLR fair value insiders trading